The "YARS2 Gene Myopathy Lactic Acidosis and Sideroblastic Anemia Type 2 Genetic Test" is a specialized diagnostic assessment offered by DNA Labs UAE, designed to detect mutations in the YARS2 gene. These mutations are responsible for a rare but severe condition that combines features of myopathy, lactic acidosis, and sideroblastic anemia. Myopathy affects muscle fibers, lactic acidosis involves an excess of lactic acid in the body, and sideroblastic anemia is a disorder where the bone marrow produces ringed sideroblasts rather than healthy red blood cells. The accurate identification of mutations in the YARS2 gene through this test is crucial for the diagnosis, management, and understanding of the patient's condition. The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to perform this genetic analysis. Conducted at DNA Labs UAE, this test represents an important tool in the diagnosis and treatment planning for patients affected by these complex, interconnected conditions.
The "MTAP Gene Myopathy Limb Girdle with Bone Fragility Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the MTAP gene. Mutations in this gene are associated with a rare genetic disorder that combines the symptoms of limb-girdle muscular dystrophy and bone fragility. This condition is characterized by progressive muscle weakness and wasting, primarily affecting the shoulder and pelvic girdles, alongside an increased susceptibility to fractures due to fragile bones.
The test is crucial for individuals showing symptoms of the disorder or those with a family history of similar conditions, as it can provide definitive genetic evidence of the disease. Early and accurate diagnosis through this test enables tailored treatment plans and management strategies to improve quality of life and mitigate the progression of symptoms.
Performed at DNA Labs UAE, a leading genetic testing facility known for its advanced diagnostic technologies and expert staff, the test costs 4400 AED. The price reflects the comprehensive analysis involved in identifying the specific genetic mutation responsible for the condition, ensuring patients and their families receive the most accurate diagnosis possible.
The GFER Gene Myopathy Mitochondrial Progressive with Congenital Cataract, Hearing Loss, and Developmental Delay Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the GFER gene. These mutations are associated with a rare, inherited disorder that affects mitochondrial function, leading to a spectrum of symptoms including progressive myopathy (muscle weakness), congenital cataracts, hearing loss, and developmental delays in affected individuals.
The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities in the GFER gene. This precise genetic testing is crucial for confirming the diagnosis, understanding the condition's progression, and guiding treatment options for patients and their families.
The cost of the GFER Gene Myopathy Mitochondrial Progressive with Congenital Cataract, Hearing Loss, and Developmental Delay Genetic Test at DNA Labs UAE is 4400 AED. This investment includes the comprehensive analysis necessary to achieve accurate results, providing essential information for managing the condition effectively.
MT-TQ Gene Myopathy is a rare genetic condition that affects muscle function and strength, leading to various degrees of muscle weakness and other symptoms. The condition is caused by mutations in the MT-TQ gene, which is involved in mitochondrial function. Mitochondria are crucial for energy production in cells, and mutations in mitochondrial genes can lead to a range of metabolic and muscular disorders, including MT-TQ gene myopathy.
To diagnose this condition, genetic testing is essential. In the United Arab Emirates, DNA Labs UAE offers a specialized genetic test aimed at identifying mutations in the MT-TQ gene. This test is a critical tool for confirming the diagnosis of MT-TQ gene myopathy, allowing for appropriate management and treatment plans to be established for affected individuals.
The cost of the MT-TQ related genetic test at DNA Labs UAE is 4400 AED. This test is performed under stringent laboratory conditions by experienced professionals, ensuring accurate and reliable results. The investment in this test is crucial for families seeking answers to unexplained muscle weakness and related symptoms, paving the way for a better understanding of the condition and potential treatment options.
The BAG3 Gene Myopathy Myofibrillar Type 6 Genetic Test is a specialized diagnostic assessment aimed at identifying mutations in the BAG3 gene, which are linked to Myofibrillar Myopathy type 6. This condition is a rare genetic disorder characterized by muscle weakness and structural abnormalities in the muscle fibers. The test plays a crucial role in the early detection and management of the disease, facilitating personalized treatment plans and genetic counseling for affected individuals and their families.
Performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, this test ensures high accuracy and reliability. The cost of the test is 4400 AED, an investment towards obtaining crucial genetic information that can significantly impact the patient's health management strategy. By identifying specific mutations in the BAG3 gene, healthcare providers can better understand the condition's progression, potential complications, and the most effective interventions for those diagnosed with Myofibrillar Myopathy type 6.
The "DES Gene Myopathy Myofibrillar Desmin Related Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the DES gene. These mutations are associated with a group of conditions known as desmin-related myopathies (DRM), which are characterized by the abnormal aggregation of desmin protein in muscle cells, leading to muscle weakness and atrophy. The test plays a crucial role in the accurate diagnosis and management of patients with symptoms suggestive of DRM, enabling healthcare professionals to tailor treatment plans effectively.
Performed using a blood sample, this genetic test focuses on analyzing the DES gene to identify any alterations that might contribute to the development of myofibrillar myopathies. It is particularly valuable for individuals presenting with muscle weakness, cardiac abnormalities, or family history of similar symptoms, offering insights into the genetic underpinnings of their condition.
DNA Labs UAE, a leading provider of genetic testing services in the region, offers this test at a cost of 4400 AED. The price reflects the sophisticated technology and expertise required to accurately detect and interpret DES gene mutations. By opting for this test at DNA Labs UAE, patients and their families can expect comprehensive support, from sample collection to result interpretation, aiding in the pursuit of a definitive diagnosis and informed approach to management and therapy.
The "CRYAB Gene Myopathy Myofibrillar Fatal Infantile Hypertrophy Alpha-B Crystallin-Related Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the CRYAB gene, which are linked to a rare and severe form of myopathy. This condition is characterized by myofibrillar disintegration, fatal infantile hypertrophy, and is associated with the alpha-B crystallin protein. The test plays a crucial role in diagnosing this genetic disorder, enabling healthcare professionals to understand the specific genetic mutation present, which can significantly impact treatment plans and patient management. The cost of the test is 4400 AED, reflecting the intricate technology and expertise required to accurately identify mutations in the CRYAB gene and provide essential information for families and medical providers dealing with this challenging condition.
The LDB3 Gene Myopathy Myofibrillar ZASP Related Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the LDB3 gene, which are associated with myofibrillar myopathy. This condition is characterized by muscle weakness and atrophy, alongside the disintegration of myofibrils, which are crucial components of muscle fibers. The LDB3 gene, also known as ZASP, plays a significant role in maintaining the structural integrity of muscle cells. Mutations in this gene can lead to various forms of myopathy, making this test an essential tool for accurate diagnosis and management of the condition.
Priced at 4400 AED, the test involves analyzing the patient's DNA to detect any genetic alterations in the LDB3 gene that may be responsible for the myofibrillar myopathy. This genetic test is particularly valuable for individuals experiencing symptoms of myopathy, or those with a family history of the condition, as it can provide a definitive diagnosis, guide treatment options, and help in understanding the risk of passing the condition on to future generations. Conducted in the advanced facilities of DNA Labs UAE, the test ensures high accuracy and reliability, offering crucial insights for patients and healthcare providers in managing myofibrillar myopathies.
The ACTA1 gene myopathy scapulohumeroperoneal genetic test is a sophisticated diagnostic procedure aimed at detecting mutations in the ACTA1 gene, which are associated with a range of myopathies. This specific gene plays a critical role in muscle function and development, and mutations can lead to conditions characterized by muscle weakness and abnormalities in the scapulohumeroperoneal regions. These conditions can vary significantly in their presentation and severity, making accurate diagnosis crucial for effective management and treatment.
Performed at DNA Labs UAE, this test provides a comprehensive analysis of the ACTA1 gene to identify any genetic alterations that may be contributing to muscle pathology. The test is priced at 4400 AED, reflecting the advanced technology and expertise required to conduct such detailed genetic analysis. By pinpointing the exact nature of the genetic mutation, healthcare providers can offer more targeted and effective interventions, improving patient outcomes. This test is an invaluable tool for individuals presenting with symptoms suggestive of ACTA1-related myopathies, offering a clear path towards a definitive diagnosis and personalized care plan.
The "STIM1 Gene Myopathy Tubular Aggregate Type 1 Genetic Test" is a specialized diagnostic examination conducted to identify mutations in the STIM1 gene, which are associated with a rare condition known as Tubular Aggregate Myopathy Type 1. This condition is characterized by muscle weakness and fatigue, with tubular aggregates found in muscle cells upon biopsy, which are indicative of abnormal calcium regulation. The STIM1 gene plays a crucial role in calcium signaling within cells, and mutations can disrupt this process, leading to the symptoms observed in affected individuals.
The test is performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. With a cost of 3200 AED, the test offers a comprehensive analysis of the STIM1 gene to confirm a diagnosis, enabling targeted management and treatment strategies for patients. It is particularly valuable for individuals showing symptoms of muscle weakness or those with a family history of Tubular Aggregate Myopathy, providing crucial insights into their condition and guiding healthcare decisions.
